European Union in talks with Moderna, BioNtech, CureVac to secure Covid-19 vaccines
The talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of 400 million doses of its potential Covid-19 vaccine, in principle available to all 27 EU nations. The information on the ongoing talks was shared by the European Commission, the EU executive arm, with EU health ministers at a meeting in Berlin on Thursday.